Lupus Nephritis New Updates
- Antiphospholipid Syndrome: A Comprehensive Clinical Review
- Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
- Lupus nephritis: redefining the treatment goals An S. De Vriese et.al. Kidney International (2025)
- The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus, Thomas Dörner et.al. Nature Reviews Rheumatology 2024.
- 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.
- Lupus Nephritis: Redefining the treatment goals, An S. De Vriese et.al; KI 2024.
-
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
- Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force
- 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment,and Management of Lupus Nephritis
- KidneyFunction and Adverse Pregnancy Outcomes in SLE
- To B or Not to B — the Role of B-Cell Depletion in Lupus Nephritis
-
2025 American College of Rheumatology (ACR) Guideline for the Treatmentof SystemicLupus Erythematosus (SLE)Efficacy and safety of belimumab in lupus nephritis patients with nephrotic syndrome: a single-centre observational retrospective study
- Finerenone as a Nonsteroidal Mineralocorticoid Receptor Antagonist for Lupus Nephritis
- In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus